Mathur, A;
Fernández-Avilés, F;
Dimmeler, S;
Hauskeller, C;
Janssens, S;
Menasche, P;
Wojakowski, W;
... Zeiher, A; + view all
(2017)
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016.
European Heart Journal
, 38
(39)
pp. 2930-2935.
10.1093/eurheartj/ehw640.
Preview |
Text
Mathur_Consensus.pdf - Published Version Download (143kB) | Preview |
Abstract
In 2006, the Task Force of the European Society of Cardiology published its consensus document on the use of autologous cell therapy for repair of the heart. Since then, there have been numerous clinical trials and analyses performed to establish the role of autologous cell therapy in the treatment of both acute and chronic cardiac disease. The majority of these studies have been Phase II clinical trials. Phase III clinical trials of autologous cell therapy have been launched (e.g. BAMI), which marks the successful progression of clinical investigation of autologous cell therapy in heart disease. The Task Force has reviewed its 2006 recommendations and the developments in this area of research and proposes updated recommendations for the future of autologous cell therapy in the heart. This article does not duplicate the many reviews on stem cells and the heart but gives considered recommendations based on the experience from the last 10 years.
Type: | Article |
---|---|
Title: | The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016 |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1093/eurheartj/ehw640 |
Publisher version: | http://dx.doi.org/10.1093/eurheartj/ehw640 |
Language: | English |
Additional information: | Copyright © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10049757 |
Archive Staff Only
![]() |
View Item |